Filed in archive
Treatment
by Rhys on July 31, 2006
Yet another diabetes medication is on the horizon, an oral treatment designed to treat Type 2. Researchers believe the medicine is an innovation in diabetes treatment.
The mechanism of action of DPP-4 inhibitors is distinct from that of any currently available class of glucose lowering agents.
Sitagliptin is a potent and highly selective DPP-4 inhibitor. DPP-4 inhibitors work by enhancing a natural body process that lowers blood sugar, the incretin system. When blood sugar is elevated, incretins work in two ways to help the body regulate high blood sugar levels: they trigger the pancreas to increase insulin and signal the liver to stop producing glucose.
Would you be willing to try it?
Permalink: Clinical Trials Begin For New Diabetes Drug
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/31317
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Clinical Trials Begin For New Diabetes Drug:
|
Rating: 9.00 out of 3 vote(s) cast.
|
Response from:
Tara
(12/17/08 10:19am)
I would be more than interested to participate in the clinical trials to cure type 1 juvenile onset diabetes. I've been suffering with diabetes since I was 11 years old, for 12 years. If there is any hope out there... Words can not express the utter joy and relief that I would feel to finally be cured of this extremely taxing and expensive disease.
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
